drugset / Trial / NCT03276494

Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access

NCT03276494

Phase 2 Completed 6 enrolled Ohio State University
NaSingle-groupOpen-labelTreatment

Summary

Hypertonic saline is used to treat elevated intracranial pressure. Intraosseous vascular access has been used to administer fluids and medications. This study combines these to administer 3% hypertonic saline via IO.

Timeline

Start
2017-04-21
Primary completion
2018-04-21
Completion
2018-04-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 3 % Other